It has been generally assumed that anti-MDA5 Ab+ DM/CADM is accompanied by mild or absent muscle involvement; however, a previous study indicated that half of their anti-MDA5 Ab+ DM/CADM patients could present with cardiac manifestations (24). This evidence concerns the gene IFIH1 and dermatomyositis.